Published in J Psychopharmacol on February 09, 2009
Satb1 ablation alters temporal expression of immediate early genes and reduces dendritic spine density during postnatal brain development. Mol Cell Biol (2011) 0.96
Performance deficits of NK1 receptor knockout mice in the 5-choice serial reaction-time task: effects of d-amphetamine, stress and time of day. PLoS One (2011) 0.95
The sodium leak channel, NALCN, in health and disease. Front Cell Neurosci (2014) 0.90
Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice. PLoS One (2009) 0.89
Transgenic mouse models for ADHD. Cell Tissue Res (2013) 0.88
Genetic association of the tachykinin receptor 1 TACR1 gene in bipolar disorder, attention deficit hyperactivity disorder, and the alcohol dependence syndrome. Am J Med Genet B Neuropsychiatr Genet (2014) 0.87
Cortical nNOS neurons co-express the NK1 receptor and are depolarized by Substance P in multiple mammalian species. Front Neural Circuits (2012) 0.87
Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder. Psychiatr Genet (2011) 0.85
The angiotensin converting enzyme inhibitor, captopril, prevents the hyperactivity and impulsivity of neurokinin-1 receptor gene 'knockout' mice: sex differences and implications for the treatment of attention deficit hyperactivity disorder. Eur Neuropsychopharmacol (2015) 0.82
The behavioural response of mice lacking NK₁ receptors to guanfacine resembles its clinical profile in treatment of ADHD. Br J Pharmacol (2014) 0.81
A lack of functional NK1 receptors explains most, but not all, abnormal behaviours of NK1R-/- mice(1). Genes Brain Behav (2015) 0.81
Regulated norepinephrine transporter interaction with the neurokinin-1 receptor establishes transporter subcellular localization. J Biol Chem (2013) 0.79
Atomoxetine reduces hyperactive/impulsive behaviours in neurokinin-1 receptor 'knockout' mice. Pharmacol Biochem Behav (2014) 0.78
Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance Test. Behav Brain Res (2015) 0.77
Methylphenidate improves the behavioral and cognitive deficits of neurogranin knockout mice. Genes Brain Behav (2012) 0.77
Perseveration by NK1R-/- ('knockout') mice is blunted by doses of methylphenidate that affect neither other aspects of their cognitive performance nor the behaviour of wild-type mice in the 5-Choice Continuous Performance Test. J Psychopharmacol (2016) 0.76
Substance P excites GABAergic neurons in the mouse central amygdala through neurokinin 1 receptor activation. J Neurophysiol (2015) 0.75
Modeling anorexia nervosa: transcriptional insights from human iPSC-derived neurons. Transl Psychiatry (2017) 0.75
The NK1R-/- mouse phenotype suggests that small body size, with a sex- and diet-dependent excess in body mass and fat, are physical biomarkers for a human endophenotype with vulnerability to attention deficit hyperactivity disorder. J Psychopharmacol (2016) 0.75
Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet (1995) 8.09
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science (2007) 6.75
Dopaminergic control of corticostriatal long-term synaptic depression in medium spiny neurons is mediated by cholinergic interneurons. Neuron (2006) 3.58
A dynamic developmental theory of attention-deficit/hyperactivity disorder (ADHD) predominantly hyperactive/impulsive and combined subtypes. Behav Brain Sci (2005) 3.54
The Child and Adolescent Psychiatric Assessment (CAPA). Psychol Med (1995) 2.99
Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev (2006) 2.96
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature (1998) 2.90
Network reset: a simplified overarching theory of locus coeruleus noradrenaline function. Trends Neurosci (2005) 2.70
Adaptive gain and the role of the locus coeruleus-norepinephrine system in optimal performance. J Comp Neurol (2005) 2.40
Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev (1991) 2.22
Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci (2007) 2.19
Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U S A (2001) 1.77
Neurokinin 1 receptor antagonism as a possible therapy for alcoholism. Science (2008) 1.77
GENECOUNTING: haplotype analysis with missing genotypes. Bioinformatics (2002) 1.74
The efferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J Comp Neurol (1985) 1.60
Neuronal mechanisms underlying attention deficit hyperactivity disorder: the influence of arousal on prefrontal cortical function. Ann N Y Acad Sci (2008) 1.58
Family-based association study of lithium-related and other candidate genes in bipolar disorder. Arch Gen Psychiatry (2008) 1.53
The genetics of attention deficit hyperactivity disorder. Hum Mol Genet (2005) 1.40
Catecholamine dysfunction in attention-deficit/hyperactivity disorder: an update. J Clin Psychopharmacol (2008) 1.39
Potent excitatory influence of prefrontal cortex activity on noradrenergic locus coeruleus neurons. Neuroscience (1998) 1.38
Attention-Deficit Hyperactivity Disorder in the post-genomic era. Eur Child Adolesc Psychiatry (2004) 1.36
Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine. Neuropsychopharmacology (2005) 1.35
The Child Attention-Deficit Hyperactivity Disorder Teacher Telephone Interview (CHATTI): reliability and validity. Br J Psychiatry (2004) 1.31
Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc Natl Acad Sci U S A (2001) 1.30
5-HT2A and alpha1b-adrenergic receptors entirely mediate dopamine release, locomotor response and behavioural sensitization to opiates and psychostimulants. Eur J Neurosci (2004) 1.26
The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry (2005) 1.22
Dopamine-serotonin interactions in attention-deficit hyperactivity disorder (ADHD). Prog Brain Res (2008) 1.16
Lack of self-administration and behavioural sensitisation to morphine, but not cocaine, in mice lacking NK1 receptors. Neuropharmacology (2002) 1.16
Neurokinin-1 receptor-expressing neurons in the amygdala modulate morphine reward and anxiety behaviors in the mouse. J Neurosci (2003) 1.15
Genetics of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am (2004) 1.12
Psychopathology in the young offspring of parents with bipolar disorder: a controlled pilot study. Psychiatry Res (2006) 1.10
A genome-wide screen for genes influencing conduct disorder. Mol Psychiatry (2004) 1.07
Dopamine in the medial prefrontal cortex controls genotype-dependent effects of amphetamine on mesoaccumbens dopamine release and locomotion. Neuropsychopharmacology (2004) 1.07
The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles. Dev Sci (2005) 1.04
Neurokinin-1 (NK-1) receptor antagonists abrogate methamphetamine-induced striatal dopaminergic neurotoxicity in the murine brain. J Neurochem (2002) 1.03
Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex. J Neurochem (1995) 1.02
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J Neurosci (2001) 1.01
Differential locomotor responses in male rats from three strains to acute methylphenidate. Int J Neurosci (2004) 0.96
Stimulation of the locus coeruleus elicits noradrenaline and dopamine release in the medial prefrontal and parietal cortex. J Neurochem (2005) 0.96
Noradrenergic neurons expressing substance P receptor (NK1) in the locus coeruleus complex: a double immunofluorescence study in the rat. Brain Res (2000) 0.94
Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res (1991) 0.93
Disruption of noradrenergic transmission and the behavioural response to a novel environment in NK1R-/- mice. Eur J Neurosci (2007) 0.93
Species differences in tachykinin receptor distribution: further evidence that the substance P (NK1) receptor predominates in human brain. J Comp Neurol (2005) 0.92
Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. Eur Neuropsychopharmacol (2006) 0.91
Dopamine D5 receptor localization on cholinergic neurons of the rat forebrain and diencephalon: a potential neuroanatomical substrate involved in mediating dopaminergic influences on acetylcholine release. J Comp Neurol (2005) 0.90
A comparison of neurokinin 1 receptor knock-out (NK1-/-) and wildtype mice: exploratory behaviour and extracellular noradrenaline concentration in the cerebral cortex of anaesthetised subjects. Neuropharmacology (2005) 0.90
Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices. Eur J Pharmacol (1995) 0.87
Substance P and cholecystokinin regulate neurochemical responses to cocaine and methamphetamine in the striatum. Life Sci (2003) 0.87
Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc Natl Acad Sci U S A (1992) 0.87
Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists. J Pharmacol Exp Ther (2002) 0.86
COGA phenotypes and linkages on chromosome 2. BMC Genet (2005) 0.84
Locally application of amphetamine into the ventral tegmental area enhances dopamine release in the nucleus accumbens and the medial prefrontal cortex through noradrenergic neurotransmission. J Pharmacol Exp Ther (1996) 0.83
Substance P excitation of rat locus coeruleus neurones. Eur J Pharmacol (1983) 0.83
Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice. J Neurochem (2004) 0.82
The neurophysiology of attention-deficit/hyperactivity disorder. Int J Psychophysiol (2005) 0.81
Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J Neurochem (1995) 0.81
The NK1 receptor is essential for the full expression of noxious inhibitory controls in the mouse. J Neurosci (2001) 0.80
Intrastriatal dopamine D1 receptor agonist-mediated motor behavior is reduced by local neurokinin 1 receptor antagonism. Synapse (2005) 0.79
Dopamine D1 receptor-stimulated release of acetylcholine in rat striatum is mediated indirectly by activation of striatal neurokinin1 receptors. J Pharmacol Exp Ther (1994) 0.78
NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res (2002) 0.78
Dopamine D(1) receptor-mediated control of striatal acetylcholine release by endogenous dopamine. Eur J Pharmacol (1999) 0.77
Facilitation by endogenous tachykinins of the NMDA-evoked release of acetylcholine after acute and chronic suppression of dopaminergic transmission in the matrix of the rat striatum. J Neurosci (2002) 0.76
Effects of intranigral substance P and neurokinin A injections on extracellular dopamine levels measured with microdialysis in the striatum and frontoparietal cortex of rats. J Neurochem (1991) 0.76
Identifying predictors of high quality care in English general practice: observational study. BMJ (2001) 9.34
Whole-genome association study of bipolar disorder. Mol Psychiatry (2008) 6.80
Diet and risk factors for coronary heart disease in Asians in northwest London. Lancet (1985) 4.83
Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature (1987) 4.59
The strength of the genetic effect. Is there room for an environmental influence in the aetiology of schizophrenia? Br J Psychiatry (1994) 4.40
Genomewide genetic linkage analysis confirms the presence of susceptibility loci for schizophrenia, on chromosomes 1q32.2, 5q33.2, and 8p21-22 and provides support for linkage to schizophrenia, on chromosomes 11q23.3-24 and 20q12.1-11.23. Am J Hum Genet (2001) 3.73
Localization of a susceptibility locus for schizophrenia on chromosome 5. Nature (1988) 3.44
Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature (1998) 2.90
The effects of aging on reaction time in a signal detection task. Psychol Aging (2001) 2.82
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Concurrent validity of the OPCRIT diagnostic system. Comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses. Br J Psychiatry (1996) 2.42
Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet (1992) 2.32
Amphiphysin heterodimers: potential role in clathrin-mediated endocytosis. Mol Biol Cell (1997) 2.12
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Quality assessment for three common conditions in primary care: validity and reliability of review criteria developed by expert panels for angina, asthma and type 2 diabetes. Qual Saf Health Care (2002) 1.89
The impact of gestational stress and prenatal growth on emotional problems in offspring: a review. Acta Psychiatr Scand (2007) 1.89
Molecular genetic evidence for heterogeneity in manic depression. Nature (1987) 1.76
Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron (1990) 1.76
Co-occurrence of ADHD and low IQ has genetic origins. Am J Med Genet B Neuropsychiatr Genet (2004) 1.69
Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr (2005) 1.69
Sensory physiology, anatomy and immunohistochemistry of Rohon-Beard neurones in embryos of Xenopus laevis. J Physiol (1984) 1.68
Attention deficit hyperactivity disorder with reading disabilities: preliminary genetic findings on the involvement of the ADRA2A gene. J Child Psychol Psychiatry (2005) 1.67
Light pulses that shift rhythms induce gene expression in the suprachiasmatic nucleus. Science (1990) 1.65
Expression and localization of alpha-adaptin isoforms. J Cell Sci (1995) 1.62
Relationship between antisocial behaviour, attention-deficit hyperactivity disorder and maternal prenatal smoking. Br J Psychiatry (2005) 1.60
Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine? J Psychopharmacol (1999) 1.51
Attitudes of general practitioners to caring for people with learning disability. Br J Gen Pract (1996) 1.51
Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience (1981) 1.50
DISC1 association, heterogeneity and interplay in schizophrenia and bipolar disorder. Mol Psychiatry (2008) 1.47
The genetics of attention deficit/hyperactivity disorder in adults, a review. Mol Psychiatry (2011) 1.46
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol (2006) 1.46
A Schwann cell mitogen accompanying regeneration of motor neurons. Nature (1997) 1.44
Possible linkage of Tourette syndrome to markers on short arm of chromosome 3 (C3p21-14) Lancet (1990) 1.42
Vitamin D status in different subgroups of British Asians. Br Med J (1976) 1.40
Genetic basis of bad behaviour in adolescents. Lancet (1997) 1.39
The links between prenatal stress and offspring development and psychopathology: disentangling environmental and inherited influences. Psychol Med (2009) 1.33
Linkage disequilibrium between two highly polymorphic microsatellites. Am J Hum Genet (1991) 1.32
Rewarding effects of opiates are absent in mice lacking the receptor for substance P. Nature (2000) 1.31
No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol O-methyltransferase activity. Am J Psychiatry (1996) 1.28
Chromosome 22q11 deletions, velo-cardio-facial syndrome and early-onset psychosis. Molecular genetic study. Br J Psychiatry (2003) 1.27
Immunocytochemical localization of glutamic acid decarboxylase in monkey striate cortex. Nature (1981) 1.26
Familial transmission of depression and antisocial behavior symptoms: disentangling the contribution of inherited and environmental factors and testing the mediating role of parenting. Psychol Med (2010) 1.25
Neural elements containing glutamic acid decarboxylase (GAD) in the dorsal lateral geniculate nucleus of the rat; immunohistochemical studies by light and electron microscopy. Neuroscience (1983) 1.21
Netrin and netrin receptor expression in the embryonic mammalian nervous system suggests roles in retinal, striatal, nigral, and cerebellar development. Mol Cell Neurosci (1997) 1.20
Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci (1983) 1.18
Fluoride-resistant acid phosphatase-containing neurones in dorsal root ganglia are separate from those containing substance P or somatostatin. Neuroscience (1982) 1.17
Polygenic dissection of the bipolar phenotype. Br J Psychiatry (2011) 1.17
An immunohistochemical study of neuronal populations containing neuropeptides or gamma-aminobutyrate within the superficial layers of the rat dorsal horn. Neuroscience (1981) 1.16
A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder. Mol Psychiatry (2000) 1.16
Stimulant and non-stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006-2009. Acta Psychiatr Scand (2012) 1.16
Endogenously produced substance P contributes to lymphocyte proliferation induced by dendritic cells and direct TCR ligation. Eur J Immunol (1999) 1.16
Remembrance of times past: the significance of c-fos in pain. Br J Anaesth (1996) 1.15
Long-term increase in the levels of c-jun mRNA and jun protein-like immunoreactivity in motor and sensory neurons following axon damage. Neurosci Lett (1991) 1.15
A procedure for combining two-point lod scores into a summary multipoint map. Hum Hered (1993) 1.14
A threonine to isoleucine missense mutation in the pericentriolar material 1 gene is strongly associated with schizophrenia. Mol Psychiatry (2008) 1.14
Predictability of oppositional defiant disorder and symptom dimensions in children and adolescents with ADHD combined type. Psychol Med (2010) 1.13
Substance P receptor (neurokinin-1)-expressing neurons in lamina I of the spinal cord encode for the intensity of noxious stimulation: a c-Fos study in rat. Neuroscience (1999) 1.12
Genome-wide association study of Alzheimer's disease with psychotic symptoms. Mol Psychiatry (2011) 1.11
GENESiS: creating a composite index of the vulnerability to anxiety and depression in a community-based sample of siblings. Twin Res (2000) 1.10
Separation of genetic influences on attention deficit hyperactivity disorder symptoms and reaction time performance from those on IQ. Psychol Med (2009) 1.10
The relationship between ADHD and key cognitive phenotypes is not mediated by shared familial effects with IQ. Psychol Med (2010) 1.10
Correlation between inositol phospholipid hydrolysis and substance P receptors in rat CNS. Nature (1984) 1.09
Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)--a pharmacoepidemiological and qualitative study. Health Technol Assess (2009) 1.08
Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts. Br J Addict (1989) 1.08
Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol Psychiatry (2005) 1.07
Peptide- and non-peptide-containing unmyelinated primary afferents: the parallel processing of nociceptive information. Philos Trans R Soc Lond B Biol Sci (1985) 1.07
Testing for gene x environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior. Am J Med Genet B Neuropsychiatr Genet (2008) 1.07
'The risks of playing it safe': a prospective longitudinal study of response to reward in the adolescent offspring of depressed parents. Psychol Med (2012) 1.06
The substantia innominata in Alzheimer's disease: an histochemical and biochemical study of cholinergic marker enzymes. Neurosci Lett (1982) 1.05
Haplotype analysis of SNAP-25 suggests a role in the aetiology of ADHD. Mol Psychiatry (2004) 1.05
A genome-wide association study of attempted suicide. Mol Psychiatry (2011) 1.04
Psychological sequelae of miscarriage: a controlled study using the general health questionnaire and the hospital anxiety and depression scale. Br J Gen Pract (1992) 1.04
Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task. Behav Brain Res (2006) 1.04
The dopamine transporter gene is associated with attention deficit hyperactivity disorder in a Taiwanese sample. Mol Psychiatry (2003) 1.03
Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience (2000) 1.03
Anticipation in mental illness. Am J Hum Genet (1994) 1.03
Changing patterns of c-fos induction in spinal neurons following thermal cutaneous stimulation in the rat. Neuroscience (1990) 1.03
FLRT3 is expressed in sensory neurons after peripheral nerve injury and regulates neurite outgrowth. Mol Cell Neurosci (2004) 1.02
Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol Psychiatry (2004) 1.02
Attitudes of general practitioners towards health care for people with intellectual disability and the factors underlying these attitudes. J Intellect Disabil Res (1997) 1.02
Genome-wide scan for genes involved in bipolar affective disorder in 70 European families ascertained through a bipolar type I early-onset proband: supportive evidence for linkage at 3p14. Mol Psychiatry (2006) 1.01
Nerve growth factor mRNA in peripheral and central rat tissues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Brain Res (1986) 1.01
Lack of normal pattern of cerebral asymmetry in familial schizophrenic patients and their relatives--The Maudsley Family Study. Schizophr Res (1999) 1.01
No support for association between the dopamine transporter (DAT1) gene and ADHD. Am J Med Genet B Neuropsychiatr Genet (2005) 1.01
Further studies on motor and sensory nerve regeneration in mice with delayed Wallerian degeneration. Eur J Neurosci (1994) 1.01
Spatial and temporal changes in signal transduction pathways during LTP. Neuron (1994) 1.01
5-hydroxytryptamine (5-HT)1A autoreceptor adaptive changes in substance P (neurokinin 1) receptor knock-out mice mimic antidepressant-induced desensitization. J Neurosci (2001) 1.01
Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol Psychiatry (2002) 1.00
GWA study data mining and independent replication identify cardiomyopathy-associated 5 (CMYA5) as a risk gene for schizophrenia. Mol Psychiatry (2010) 1.00
A genetic study of ADHD and activity level in infancy. Genes Brain Behav (2009) 0.99
Displaced ganglion cells and the accessory optic system of pigeon. J Comp Neurol (1981) 0.99
Distinct GABAA receptor alpha subunit mRNAs show differential patterns of expression in bovine brain. Neuron (1988) 0.99
Association between the alpha(1a) calcium channel gene CACNA1A and idiopathic generalized epilepsy. Neurology (2001) 0.99
Interruptions during general practice consultations--the patients' view. Fam Pract (1996) 0.99
Hypertension and the post-carotid endarterectomy cerebral hyperperfusion syndrome. Eur J Vasc Endovasc Surg (2010) 0.98
Genetic association study of GABRA2 single nucleotide polymorphisms and electroencephalography in alcohol dependence. Neurosci Lett (2011) 0.97